Department of Pathology, School of Medicine, Kurume University, Kurume, Fukuoka, Japan.
Int J Oncol. 2013 Aug;43(2):457-68. doi: 10.3892/ijo.2013.1982. Epub 2013 Jun 12.
For an accurate understanding of mantle cell lymphoma (MCL), molecular behavior could be staged into two major events: lymphomagenesis with the t(11;14) translocation (initiation), and evolution into a more aggressive form (transformation). Unfortunately, it is still unknown which genes contribute to each event. In this study, we performed cDNA microarray experiments designed based on the concept that morphologically heterogeneous MCL samples would provide insights into the role of aberrant gene expression for both events. A total of 15 MCLs were collected from the files, which include a total of 237 MCL patients confirmed by histology as CCND1-positive. We posited four stepwise morphological grades for MCL: MCL in situ, MCL with classical form (cMCL), MCL with aggressive form (aMCL), and MCL with intermediate morphology between classical and aggressive forms at the same site (iMCL). To identify genes involved in initiation, we compared the tumor cells of MCL in situ (n=4) with normal mantle zone B lymphocytes (n=4), which were selected by laser microdissection (LMD). To identify genes contributing to transformation, we selected the overlapping genes differentially expressed between both cMCL (n=4) vs. aMCL (n=5) and classical vs. aggressive areas in iMCL (n=2) obtained by LMD. A significant number of genes (n=23, p=0.016) belonging to the Wnt signaling pathway were differentially expressed in initiation. This specific activation was confirmed by immuno-histochemistry, as MCL in situ had nuclear localization of phosphorylated-β-catenin with high levels of cytoplasmic Wnt3 staining. For transformation, identified 60 overlapping genes included a number of members of the p53 interaction network (CDC2, BIRC5 and FOXM1), which is known to mediate cell cycle progression during the G2/M transition. Thus, we observe that the Wnt signaling pathway may play an important role in initial lymphomagenesis in addition to t(11;14) translocations, and that specific mitotic regulators facilitate transformation into more aggressive forms.
为了准确理解套细胞淋巴瘤(MCL),分子行为可以分为两个主要事件:带有 t(11;14)易位的淋巴瘤发生(起始),以及演变为更具侵袭性的形式(转化)。不幸的是,目前尚不清楚哪些基因参与了每个事件。在这项研究中,我们进行了基于以下概念的 cDNA 微阵列实验:形态异质性 MCL 样本将提供对异常基因表达在两个事件中的作用的深入了解。总共从档案中收集了 15 例 MCL,其中包括总共 237 例经组织学证实为 CCND1 阳性的 MCL 患者。我们为 MCL 提出了四个逐步的形态学等级:原位 MCL、具有经典形态的 MCL(cMCL)、具有侵袭性形态的 MCL(aMCL)和具有经典和侵袭性形态之间的中间形态的 MCL(iMCL)。为了鉴定与起始相关的基因,我们比较了原位 MCL 肿瘤细胞(n=4)与通过激光微切割(LMD)选择的正常套区 B 淋巴细胞(n=4)。为了鉴定促进转化的基因,我们选择了在通过 LMD 获得的 cMCL(n=4)与 aMCL(n=5)之间以及 iMCL 中经典与侵袭性区域之间差异表达的重叠基因。属于 Wnt 信号通路的大量基因(n=23,p=0.016)在起始时差异表达。通过免疫组织化学证实了这种特异性激活,因为原位 MCL 具有高细胞质 Wnt3 染色的磷酸化-β-连环蛋白核定位。对于转化,鉴定出的 60 个重叠基因包括许多 p53 相互作用网络的成员(CDC2、BIRC5 和 FOXM1),已知这些成员在 G2/M 转换期间调节细胞周期进程。因此,我们观察到 Wnt 信号通路除了 t(11;14)易位外,可能在初始淋巴瘤发生中发挥重要作用,并且特定的有丝分裂调节剂促进向更具侵袭性的形式转化。